vyxeos liposomal
medison pharma ltd - cytarabine; daunorubicin as hcl - powder for concentrate for solution for infusion - cytarabine 100 mg/vial; daunorubicin as hcl 44 mg/vial - daunorubicin and cytarabine - vyxeos liposomal is indicated for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukaemia (t-aml) or aml with myelodysplasia-related changes (aml-mrc).
vyxeos liposomal (previously known as vyxeos)
jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - leukemia, myeloid, acute - antineoplastic agents - vyxeos liposomal is indicated for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukaemia (t-aml) or aml with myelodysplasia-related changes (aml-mrc).
vyxeos powder
jazz pharmaceuticals ireland limited - daunorubicin; cytarabine - powder - 44mg; 100mg - daunorubicin 44mg; cytarabine 100mg - antineoplastic agents
vyxeos powder for concentrate for solution for infusion
jazz pharmaceutical ireland ltd, ireland - daunorubicin,cytarabine - powder for concentrate for solution for infusion - 2.2,5 mg/ml,